Management of Hypertension in Relation to Acute Coronary Syndromes and Revascularisation

Author(s): Michael Kuhl, Gregory Y.H. Lip, Chetan Varma

Journal Name: Current Pharmaceutical Design

Volume 13 , Issue 25 , 2007

Become EABM
Become Reviewer


In patients with acute coronary syndromes (ACS), hypertension is common. The type of ACS and severity of hypertension would determine the treatment algorithm. In ST elevation myocardial infarction (MI), time to reperfusion is essential whereas in malignant hypertension the reduction of blood pressure to prevent end organ damage is the priority. Many therapeutic drugs available for ACS and hypertension are commonly used to treat both these conditions simultaneously. Once the ACS is treated medically, revascularization therapy is likely to be considered. Importantly, optimization of hypertension management may prevent subsequent complications. In this review, we discuss the frequency of hypertension and ACS as single clinical conditions, as well as combined presentations. The pathophysiology of myocardial perfusion in hypertensive patients and the effect of blood pressure (BP) normalization is discussed. This review focuses on treatment strategies from a non-interventional and interventional perspective. Finally, current medications used in treating hypertension in ACS will be compared with regards to their mode of action and prognostic value.

Keywords: Hypertension, acute coronary syndrome, myocardial infarction, revascularisation

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [2556 - 2566]
Pages: 11
DOI: 10.2174/138161207781663046
Price: $65

Article Metrics

PDF: 9